Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Article in Journal of Translational Medicine (January 2024)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
Article in Cureus (August 2022)
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review
Article in Breast Cancer Targets and Therapy (January 2022)